Cyclin D(1) expression during rat mammary tumor development and its potential role in the resistance of the Copenhagen rat

BACKGROUND: Resistance to mammary tumorigenesis in Copenhagen rats is associated with loss of early preneoplastic lesions known as intraductal proliferations. The cause of this disappearance, however, is unknown. RESULTS: There were no differences in the numbers of lesions in mammary whole-mounts prepared from Copenhagen or Wistar-Furth rats at 20 or 30 days after N-methyl-N-nitrosourea treatment, but at 37 days there were significantly fewer lesions in Copenhagen glands. Furthermore, lesions in Copenhagen glands were exclusively intraductal proliferations, whereas in Wistar-Furth glands more advanced lesions were also present. Immunohistochemical staining showed frequent cyclin D(1) overexpression in Wistar-Furth lesions at 37 days, but not in Copenhagen lesions. There were, however, no differences in p16(INK4a) protein expression, bromodeoxyuridine labeling and apoptotic indices, or mast cell infiltration between Copenhagen and Wistar-Furth lesions at any time. CONCLUSIONS: Overexpression of cyclin D(1) in preneoplastic lesions may be important in the development of mammary tumors in susceptible rats, although this overexpression does not appear to cause significant changes in cell kinetics. Furthermore, the low levels of cyclin D(1) expression in Copenhagen intraductal proliferations may play a role in the resistance of these rats to mammary tumorigenesis

Immunodetectable cyclin D 1 is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions

Cyclin D1 is associated with cell cycle regulation and has more recently been shown to stimulate the transcriptional functions of the oestrogen receptor (ER). Furthermore, in normal breast there is a negative association between expression of ER and the proliferation marker Ki67 indicating that either ER positive cells are non-dividing or that the receptor is down-regulated as cells enter cycle. This important relationship breaks down in many ER-positive cancers and precancerous breast lesions where the receptor is often detected on proliferating cells. The aims of the present study were to determine the interplay between ER, Ki67 and cyclin D 1 in individual cells within the spectrum of human breast lesions ranging from normal to invasive carcinoma by using dual staining immunofluorescence. We found that in normal breast there was a strong positive association between ER and cyclin D 1 expression. In contrast there was a strong negative association between cyclin D 1 and Ki67 expression. Similar findings were seen for the other precancerous and cancerous breast lesions. Thus immunodetectable cyclin D 1 within individual cells does not appear to be associated with cell cycle progression in the benign or malignant breast but instead may have important interactions with ER. © 2001 Cancer Research Campaign http://www.bjcancer.co

HIV-1 expression induces cyclin D(1) expression and pRb phosphorylation in infected podocytes: cell-cycle mechanisms contributing to the proliferative phenotype in HIV-associated nephropathy

BACKGROUND: The aberrant cell-cycle progression of HIV-1-infected kidney cells plays a major role in the pathogenesis of HIV-associated nephropathy, however the mechanisms whereby HIV-1 induces infected glomerular podocytes or infected tubular epithelium to exit quiescence are largely unknown. Here, we ask whether the expression of HIV-1 genes in infected podocytes induces cyclin D(1) and phospho-pRb (Ser780) expression, hallmarks of cyclin D1-mediated G(1) → S phase progression. RESULTS: We assessed cyclin D(1) and phospho-pRb (Ser780) expression in two well-characterized models of HIV-associated nephropathy pathogenesis: HIV-1 infection of cultured podocytes and HIV-1 transgenic mice (Tg26). Compared to controls, cultured podocytes expressing HIV-1 genes, and podocytes and tubular epithelium from hyperplastic nephrons in Tg26 kidneys, had increased levels of phospho-pRb (Ser780), a target of active cyclin D(1)/cyclin-dependent kinase-4/6 known to promote G(1) → S phase progression. HIV-1-infected podocytes showed markedly elevated cyclin D(1) mRNA and cyclin D(1) protein, the latter of which did not down-regulate during cell-cell contact or differentiation, suggesting post-transcriptional stabilization of cyclin D(1) protein levels by HIV-1. The selective suppression of HIV-1 transcription by the cyclin-dependent kinase inhibitor, flavopiridol, abrogated cyclin D(1) expression, underlying the requirement for HIV-1 encoded products to induce cyclin D(1). Indeed, HIV-1 virus deleted of nef failed to induce cyclin D(1) mRNA to the level of other single gene mutant viruses. CONCLUSIONS: HIV-1 expression induces cyclin D(1) and phospho-pRb (Ser780) expression in infected podocytes, suggesting that HIV-1 activates cyclin D1-dependent cell-cycle mechanisms to promote proliferation of infected renal epithelium

Integrins engage mitochondrial function for signal transduction by a mechanism dependent on Rho GTPases.

We show here the transient activation of the small GTPase Rac, followed by a rise in reactive oxygen species (ROS), as necessary early steps in a signal transduction cascade that lead to NFkappaB activation and collagenase-1 (CL-1)/matrix metalloproteinase-1 production after integrin-mediated cell shape changes. We show evidence indicating that this constitutes a new mechanism for ROS production mediated by small GTPases. Activated RhoA also induced ROS production and up-regulated CL-1 expression. A Rac mutant (L37) that prevents reorganization of the actin cytoskeleton prevented integrin-induced CL-1 expression, whereas mutations that abrogate Rac binding to the neutrophil NADPH membrane oxidase in vitro (H26 and N130) did not. Instead, ROS were produced by integrin-induced changes in mitochondrial function, which were inhibited by Bcl-2 and involved transient membrane potential loss. The cells showing this transient decrease in mitochondrial membrane potential were already committed to CL-1 expression. These results unveil a new molecular mechanism of signal transduction triggered by integrin engagement where a global mitochondrial metabolic response leads to gene expression rather than apoptosis

Cyclin D1 Expression in Laryngeal Cancer.

INTRODUCTION : Laryngeal squamous-cell carcinomas (LSCC) comprise the vast majority (96%) of laryngeal malignancies. Larynx has several clinical and molecular peculiarities. The American Cancer Society classifies the larynx as part of the respiratory system, separate from the oral cavity and pharynx. Most of these tumors originate in the glottis and supra glottis; the sub glottis is an extremely rare site of origin. The estimated incidence of cervical lymph-node metastases with no obvious primary site (occult T) is from 3% to 9% 5, 6 and some of these might reasonably have a laryngeal (especially supra glottic) origin. The male/female ratio for the incidence of laryngeal cancer is much higher than in other parts of the head and neck. Differences in chromosomal pattern and carcinogenic progression between LSCC and other head-and-neck squamous-cell carcinomas (HNSCC) have been detected by comparative genomic studies. The prognostic stratification of LSCC patients is inadequate since similar patients, affected by tumors with similar clinico pathological features and undergoing the same treatment, may differ widely in prognosis, probably due to the extreme biological heterogeneity of LSCC, which contributes to the lack of consistency in treatment planning. So a different approach to LSCC, based on genetics and molecular biology in addition to the clinical and histological approach, is required to overcome these obstacles and to reduce cancer-related mortality in LSCC patients. Systematic study of biological markers might be integrated into clinical practice in the phases of prevention as ‘molecular epidemiology’ of diagnosis as ‘molecular diagnostics’, of prognostic assessment and treatment selection as ‘molecular characterization’, and of the synthesis of new drugs as ‘molecular targeting’. Objectives : 1. To analyze the expression of Cyclin D1 – a cell cycle regulatory protein, in squamous cell carcinoma of larynx patients 2. To correlate the expression of Cyclin D1 with clinical and pathological parameters like Age of the patient, Extent of tumor and Nodal status, Grade and Stage of the tumor, any predilection for sub sites in the larynx. 3. To investigate whether over expression of Cyclin D1 is associated with an increased likelihood of tumor recurrence and over expression of Cyclin D1 could serve to identify a proportionally distinctive group of patients. CONCLUSION : In this study only the Extent of tumor (T status) correlates with the over expression of Cyclin D1. Otherwise this study did not support the hypothesis that Cyclin D1 over expression is an independent significant predictor for Stage of disease, Nodal status, Grade of tumor or Recurrence of disease. Possibly Cyclin D1 gene amplification may be better prognosticator than it’s protein over expression as studied by Bellacosa et.al., Kyomoto et.al, Distinct molecular pathways at different anatomical regions involved, not only in the abnormal function of the Cyclin D1 cell cycle regulator, but also in the development of tumors without Cyclin D1 alteration. Discovery Today: Diseas

Thymic Stromal Lymphopoietin Induces Migration in Human Airway Smooth Muscle Cells

Airway remodeling due to increased airway smooth muscle (ASM) mass, likely due to enhanced migration and proliferation, has been shown to be highly associated with decline in lung function in asthma. Thymic stromal lymphopoietin (TSLP) is an IL-7-like, pro-allergic cytokine that has been shown to be necessary and sufficient for the development of allergic asthma. Human ASM (HASM) cells express TSLP receptor (TSLPR), the activation of which leads to enhanced release of proinflammatory mediators such as IL-6, CCL11/eotaxin-1, and CXCL8/IL-8. We show here that TSLP induces HASM cell migration through STAT3 activation since lentiviral-shRNA inhibition of STAT3 abrogated the TSLP-induced cell migration. Moreover, TSLP induced multiple cytoskeleton changes in HASM cells such as actin polymerization, cell polarization, and activation of small GTPase Rac1. Collectively, our data suggest a pro-migratory function of TSLP in ASM remodeling and provides better rationale for targeting TSLP/TSLPR pathway for therapeutic approaches in allergic asthma

ERK Activation and Cell Growth Require CaM Kinases in MCF-7 Breast Cancer Cells

Previous studies on MCF-7 breast cancer cells have shown that the G-protein coupled receptor (GPCR) agonist carbachol increases intracellular calcium levels and the activation of extracellular signal-regulated kinase (ERK). Calcium and calmodulin regulate the calcium/calmodulin- dependent kinase (CaM kinase) family of proteins that have been proposed to regulate ERK and gene transcription. Our results suggest that both estrogen (E2) and carbachol treatment of MCF-7 breast cancer cells trigger phosphorylation of ERK I /2 and the transcription factor Elk-1. Carbachol and estrogen triggered nearly a four- to sixfold increase in MCF-7 cell proliferation by 96 h, respectively. Carbachol-stimulated ERK activation and cell growth was completely blocked by the Muscarinic M3- subtype GPCR inhibitor, 4-DAMP, and siRNA against the M3-subtype GPCR. Interestingly, blockade of CaM KK with the selective inhibitor ST0-609 prevented carbachol activation CaM KI, ERK, Elk-1 , and cell gro\vth. Consistent with these observations, knockdown of CaM KKa and CaM Kly with shRNA-containing plas1nids blocked ERK activation by carbachol. In addition, Elk-I phosphorylation and luciferase activity in response to carbachol treat1nent was also dependent upon CaM kinases and was inhibited by U0126, ST0-609, and siRNA knockdown of CaM kinases and ERK2. Finally, blockade of either CaM KK (with ST0-609) or ERK (with U0126) activities resulted in the inhibition of carbachol- and estrogen-mediated cyclin Dl expression and MCF-7 cell growth. Taken together, our results suggest that carbachol treatment of MCF-7 cells activates CaM KI, ERK, the transcription factor Elk-1 , cyclin D 1, and cell grovvth through CaM KK

The elements of human cyclin D1 promoter and regulation involved

Cyclin D1 is a cell cycle machine, a sensor of extracellular signals and plays an important role in G1-S phase progression. The human cyclin D1 promoter contains multiple transcription factor binding sites such as AP-1, NF-қB, E2F, Oct-1, and so on. The extracellular signals functions through the signal transduction pathways converging at the binding sites to active or inhibit the promoter activity and regulate the cell cycle progression. Different signal transduction pathways regulate the promoter at different time to get the correct cell cycle switch. Disorder regulation or special extracellular stimuli can result in cell cycle out of control through the promoter activity regulation. Epigenetic modifications such as DNA methylation and histone acetylation may involved in cyclin D1 transcriptional regulation